Simi Valley, CA, United States of America

Andrew Stewart Tasker

USPTO Granted Patents = 66 (Patent Applications = 12)

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 14 (Patent Applications = 22)

Average Co-Inventor Count = 6.1

ph-index = 15

Forward Citations = 601(Granted Patents)

DiyaCoin

= 0.56

Inventors with similar research interests:

Location History:

Lindenhurst, IL (US) (1993 - 1994)
Gurnee, IL (US) (1997 - 2008)
Simi Valley, CA (US) (2001 - 2023)

Company Filing History:

Abbott Laboratories Corporation

patents

2 out of 1,860

University of Pittsburgh

Accent Therapeutics, Inc.

Suvalent Therapeutics, Inc.

patents

9. 1 out of 832,680

Other

patents

Years Active: 1993-2025

where 'Filed Patents' based on already Granted Patents

66 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12398151 - Sumo inhibitor compounds and uses thereof (2025-08-26),

2. 12233065 - Inhibitors of RNA helicase DHX9 and uses thereof (2025-02-25),

3. 12162867 - Inhibitors of RNA helicase DHX9 and uses thereof (2024-12-10),

4. 12110285 - Substituted pyridine derivatives as SARM1 inhibitors (2024-10-08),

5. 11845754 - Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity (2023-12-19),

6. 11629136 - Substituted pyridine derivatives as SARM1 inhibitors (2023-04-18),

7. 11155560 - Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity (2021-10-26),

8. 9394297 - Amides as pim inhibitors (2016-07-19),

9. 9346801 - Substituted 7-oxo-pyrido[2,3-d]pyrimidines and methods of use (2016-05-24),

10. 9321756 - Azole compounds as PIM inhibitors (2016-04-26),

11. 9187486 - Bicyclic pyridazine compounds as Pim inhibitors (2015-11-17),

12. 9090593 - Bicyclic compounds as Pim inhibitors (2015-07-28),

13. 8772481 - Aza- and diaza-phthalazine compounds as P38 map kinase modulators and methods of use thereof (2014-07-08),

14. 8642624 - Substituted alkylamine derivatives and methods of use (2014-02-04),

15. 8497269 - Phthalazine compounds as p38 map kinase modulators and methods of use thereof (2013-07-30),

Title: Andrew Stewart Tasker: A Trailblazer in Innovation

Introduction:

Andrew Stewart Tasker, a remarkable inventor based in Simi Valley, CA, has captivated the world of innovation with his relentless drive and passion for pushing the boundaries of what is possible. His impressive portfolio of 62 patents showcases his dedication to pioneering advancements in various fields.

Latest Patents:

Among his latest patents, Andrew Stewart Tasker has introduced groundbreaking inventions such as Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity and Substituted pyridine derivatives as SARM1 inhibitors. These inventions demonstrate his commitment to developing solutions that have significant implications for the medical and pharmaceutical industries.

Career Highlights:

Andrew Stewart Tasker's illustrious career is highlighted by his tenure at Abbott Laboratories Corporation, where he has consistently delivered innovative solutions that have shaped the industry. His expertise and visionary approach have earned him a reputation as a standout figure in the world of inventors.

Collaborations:

Throughout his career, Andrew Stewart Tasker has collaborated with esteemed colleagues such as Liping H Pettus and Shimin Xu. These collaborations have led to the development of groundbreaking technologies and inventions that have made a lasting impact on the field of innovation.

Conclusion:

In conclusion, Andrew Stewart Tasker's unwavering commitment to innovation and his remarkable contributions to the world of inventors continue to inspire future generations of innovators. His legacy serves as a testament to the power of relentless drive and passion in driving meaningful change and advancements in numerous industries.

This text is generated by artificial intelligence and may not be accurate.